Latest news with #RM70.2m
Yahoo
30-05-2025
- Business
- Yahoo
Lotus Circular Berhad Third Quarter 2025 Earnings: EPS: RM0.024 (vs RM0.039 in 3Q 2024)
Revenue: RM70.2m (up 12% from 3Q 2024). Net income: RM3.46m (down 39% from 3Q 2024). Profit margin: 4.9% (down from 9.1% in 3Q 2024). The decrease in margin was driven by higher expenses. EPS: RM0.024 (down from RM0.039 in 3Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Lotus Circular Berhad shares are up 4.2% from a week ago. Be aware that Lotus Circular Berhad is showing 2 warning signs in our investment analysis that you should know about... Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
22-05-2025
- Business
- Yahoo
Master Tec Group Berhad First Quarter 2025 Earnings: EPS: RM0.004 (vs RM0.005 in 1Q 2024)
Revenue: RM70.2m (down 14% from 1Q 2024). Net income: RM4.47m (up 9.0% from 1Q 2024). Profit margin: 6.4% (up from 5.0% in 1Q 2024). The increase in margin was driven by lower expenses. EPS: RM0.004. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Master Tec Group Berhad's share price is broadly unchanged from a week ago. You should always think about risks. Case in point, we've spotted 1 warning sign for Master Tec Group Berhad you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21-05-2025
- Business
- Yahoo
Master Tec Group Berhad First Quarter 2025 Earnings: EPS: RM0.004 (vs RM0.005 in 1Q 2024)
Revenue: RM70.2m (down 14% from 1Q 2024). Net income: RM4.47m (up 9.0% from 1Q 2024). Profit margin: 6.4% (up from 5.0% in 1Q 2024). The increase in margin was driven by lower expenses. EPS: RM0.004. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Master Tec Group Berhad's share price is broadly unchanged from a week ago. You should always think about risks. Case in point, we've spotted 1 warning sign for Master Tec Group Berhad you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
